Jasper van der Lugt - Princess Máxima Center for Pediatric Oncology

基本信息

浏览量：3

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 101 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Unusual Partners: Γδ-Tcr-based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline Gliomas

Konstantinos Vazaios, Patricia Hernández López,Tineke Aarts-Riemens, Annet Daudeij,Vera Kemp,Rob C Hoeben,Trudy Straetemans,Esther Hulleman,Friso G Calkoen,Jasper van der Lugt,Jürgen Kuball

International journal of molecular sciencesno. 5 (2025)

引用0浏览0WOS引用

CTNI-09. TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG): RESULTS FROM PATIENTS ON A DRUG HOLIDAY (DH) IN THE PHASE 2 FIREFLY-1 TRIAL

Neuro-Oncologyno. Supplement_8 (2024)

引用0浏览0引用

LGG-44. CLINICAL AND MOLECULAR TUMOR CHARACTERISTICS OF ‘HIGHER RISK’ PEDIATRIC LOW-GRADE GLIOMAS

Tiago Rijsdijk,Julie A. S. Lammers,Eelco W. Hoving,Pieter Wesseling,Bastiaan B. J. Tops,Lennart Kester,Lisethe Meijer, Netteke A. Y. Schouten-van Meeteren, Karina J. Kersbergen,Jasper van der Lugt,Raoll Hoogendijk,Mariette E. G. Kranendonk

Neuro-Oncology（2024）

引用0浏览0引用

Author Correction: the Type II RAF Inhibitor Tovorafenib in Relapsed/refractory Pediatric Low-Grade Glioma: the Phase 2 FIREFLY-1 Trial

Nature Medicine（2024）

引用32浏览0WOSNATURE引用

NCOG-05. HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN THE PHASE 2 FIREFLY-1 (PNOC026) TRIAL OF THE TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG)

Neuro-Oncologyno. Supplement_8 (2024)

引用0浏览0引用

EPID-03. CURE FRACTION AND LONG TERM SURVIVAL ESTIMATES FOR PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS IN EUROPE – RESULTS OF THE POPULATION-BASED EUROCARE PROJECT

Raoull Hoogendijk,Riccardo Capocaccia,Jasper van der Lugt,Mariette Kranendonk,Eelco Hoving,Pieter Wesseling,Otto Visser,Dannis van Vuurden,Gemma Gatta,Henrike Karim-Kos

NEURO-ONCOLOGY (2024)

引用0浏览0引用

OV Modulators of the Paediatric Brain TIME: Current Status, Combination Strategies, Limitations and Future Directions

Konstantinos Vazaios, Ronja E. van Berkum,Friso G. Calkoen,Jasper van der Lugt,Esther Hulleman

International Journal of Molecular Sciencesno. 9 (2024): 5007-5007

引用1浏览0WOS引用

EPID-02. A CLINICALLY RELEVANT SURVIVAL COMPARISON OF PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS FOR 31 EUROPEAN COUNTRIES – POPULATION-BASED RESULTS FROM THE EUROCARE-6 PROJECT

Raoull Hoogendijk,Riccardo Capocaccia,Jasper van der Lugt,Mariëtte Kranendonk,Eelco Hoving,Pieter Wesseling,Otto Visser,Dannis van Vuurden,Gemma Gatta,Henrike Karim-Kos

Neuro-Oncologyno. Supplement_4 (2024): 0-0

引用0浏览0引用

Profiling the Immune Populations in Paediatric Brain Tumours: the MIMIC Program

Tiago Carvalheiro, Joyce I. Meesters-Ensing,Raoull Hoogendijk,Mariette Kranendonk,Eelco W. Hoving,Friso G. Calkoen,Jasper van der Lugt,Stefan Nierkens

EUROPEAN JOURNAL OF IMMUNOLOGY (2024): 1597-1597

引用0浏览0引用

Omnigene-Guttm Ensures Fecal Microbiome Stability in the Pediatric Population

Raoull Hoogendijk, Thijs J. M. van den Broek, Hyunju Lee,Sabine Mueller,Cassie Kline,John Bianco,Janetta Top, Marcel R. de Zoete,Lennart Kester,Friso Calkoen,Jasper van der Lugt

AMB Expressno. 1 (2024): 1-10

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn